Related Experiment Video
Updated: Mar 14, 2026
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
Mycoplasmal lipoprotein p37 binds human protein HER2
Jun Wu1, Lijuan Wu1, Cheng Fang1
1College of Health Sciences and Nursing, Wuhan Polytechnic University, Wuhan 430023, China.
Abstract:
Mycoplasmas are a group of microbes that can cause human diseases. The mycoplasmal lipoprotein p37 promotes cancer metastasis, at least in part, by interacting with EGFR. In this study, we show that the p37 lipoprotein binds another member of the EGFR family, HER2, through the HER2 extracellular domain. The binding of p37-HER2 promotes phosphorylation of HER2 and activates the downstream signaling molecule Erk1/2. Because the HER2 signaling pathway contributes to breast tumor metastasis, our results imply that the mycoplasmal lipoprotein p37 may also be involved in breast cancer metastasis. This study contributes to our understanding of mycoplasmal lipoprotein p37 function and its potential involvement in tumorigenesis.
Insights
The mycoplasma p37 protein binds HER2, activating cancer-promoting pathways. This finding suggests p37 may contribute to breast cancer metastasis and tumorigenesis.
Area of Science:
- Microbiology
- Oncology
- Molecular Biology
Background:
- Mycoplasmas are pathogenic microbes.
- The mycoplasmal lipoprotein p37 is implicated in promoting cancer metastasis through interactions with the Epidermal Growth Factor Receptor (EGFR) family.
- Understanding the specific molecular mechanisms of p37 in cancer progression is crucial.
Purpose of the Study:
- To investigate the interaction between mycoplasmal lipoprotein p37 and HER2, another member of the EGFR family.
- To elucidate the downstream signaling consequences of p37-HER2 binding.
- To assess the potential role of p37 in breast cancer metastasis.
Main Methods:
- Protein-ligand binding assays to confirm p37 interaction with HER2.
- Analysis of HER2 phosphorylation levels upon p37 binding.
- Assessment of Erk1/2 activation downstream of HER2 signaling.
Main Results:
- The mycoplasmal lipoprotein p37 directly binds to the extracellular domain of HER2.
- p37-HER2 interaction leads to increased HER2 phosphorylation.
- Activation of the downstream signaling molecule Erk1/2 was observed.
Conclusions:
- Mycoplasmal lipoprotein p37 interacts with HER2, activating a pathway implicated in breast cancer metastasis.
- These findings suggest a novel mechanism by which mycoplasmas may contribute to tumorigenesis.
- Further research into p37's role in breast cancer is warranted.
More Related Videos
09:39Exploring Biomolecular Interaction Between the Molecular Chaperone Hsp90 and Its Client Protein Kinase Cdc37 using Field-Effect Biosensing Technology
Published on: March 31, 2022
10:05Hydrogel Nanoparticle Harvesting of Plasma or Urine for Detecting Low Abundance Proteins
Published on: August 7, 2014